Type: | Studiedocumentatie |
Ziektebeelden: | AML |
Leeftijd: | ≥ 18 jr |
Fase: | N.v.t. |
Lijn: | N.v.t. |
Status: | Open |
Locatie: | Amsterdam UMC |
Volledige titel | Characterization of buffy-coat-derived granulocytes for clinical use: - identifying clinical and laboratory parameters for decision making A pilot study |
Documenten |
|
Samenvatting met in- en exclusiecriteria |
Overall aim
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
|
Veiligheidsinformatie |
|
Niet geregistreerde geneesmiddelen |
nvt |
Geregistreerde geneesmiddelen |
nvt |
NB |
|
Principal investigator Amsterdam UMC | Erfan Nur |
Principal investigator elders |